Australia releases guidance on Class III devices and active implantables:
This article was originally published in Clinica
Executive Summary
Australia's Therapeutic Goods Administration (TGA) has published "Australian Medical Devices Guidance Document 13 - variants for Class III and AIMD Medical Devices", which addresses the criteria for entering Class III and active implantable medical devices in the Australian Register of Therapeutic Goods (ARTG). It covers "same kind of medical device", unique product identifiers and variants. The document is one of a series explaining key areas of the new regulatory system for medical devices. The guidance is available via: www.tga.gov.au/new/new.htm
You may also be interested in...
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.
Cidara Offloads Rezzayo, Will Focus On Universal Flu Preventative
Cidara conferred global rights to its novel antifungal to marketing partner, Mundipharma, while reacquiring a flu prophylaxis it licensed to J&J in 2021 and gaining $240m in new funding to back development.